Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Synchronous Primary Carcinoma of Breast and Ovary Versus Ovarian Metastases.

Yadav BS, Sharma SC, Robin TP, Sams S, Elias AD, Kaklamani V, Kelly Marcom P, Schaefer S, Morris GJ.

Semin Oncol. 2015 Apr;42(2):e13-e24. doi: 10.1053/j.seminoncol.2014.12.020. Epub 2015 Jan 12. Review. No abstract available.

PMID:
25843740
2.

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Sep;12(9):1326-38.

PMID:
25190698
3.

Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.

Gordon AC, Gradishar WJ, Kaklamani VG, Thuluvath AJ, Ryu RK, Sato KT, Gates VL, Salem R, Lewandowski RJ.

J Vasc Interv Radiol. 2014 Oct;25(10):1523-32, 1532.e1-2. doi: 10.1016/j.jvir.2014.07.007. Epub 2014 Aug 22.

PMID:
25156827
4.

Antipsychotic treatment in breast cancer patients.

Rahman T, Clevenger CV, Kaklamani V, Lauriello J, Campbell A, Malwitz K, Kirkland RS.

Am J Psychiatry. 2014 Jun;171(6):616-21. doi: 10.1176/appi.ajp.2013.13050650. Review.

PMID:
24880509
5.

Predicting benefit from imatinib: are we close?

Gandhi MD, Kaklamani VG.

Leuk Lymphoma. 2014 Nov;55(11):2421-2. doi: 10.3109/10428194.2014.909041. Epub 2014 Apr 22. No abstract available.

PMID:
24684225
6.

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.

Jackson SA, Davis AA, Li J, Yi N, McCormick SR, Grant C, Fallen T, Crawford B, Loranger K, Litton J, Arun B, Vande Wydeven K, Sidani A, Farmer K, Sanders M, Hoskins K, Nussbaum R, Esserman L, Garber JE, Kaklamani VG; Northwestern Cancer Genetics Group.

Cancer. 2014 May 15;120(10):1557-64. doi: 10.1002/cncr.28577. Epub 2014 Feb 12.

7.

Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer.

Reddy SM, Sadim M, Li J, Yi N, Agarwal S, Mantzoros CS, Kaklamani VG.

Br J Cancer. 2013 Aug 20;109(4):872-81. doi: 10.1038/bjc.2013.441. Epub 2013 Aug 6.

8.

Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative.

Kaklamani VG, Hoffmann TJ, Thornton TA, Hayes G, Chlebowski R, Van Horn L, Mantzoros C.

Breast Cancer Res Treat. 2013 Jun;139(2):461-8. doi: 10.1007/s10549-013-2546-6. Epub 2013 Apr 30.

9.

Paradigm of polyendocrine therapy in endocrine responsive breast cancer: the role of fulvestrant.

Nelson V, Rademaker A, Kaklamani V.

Chin Clin Oncol. 2013 Mar;2(1):10. doi: 10.3978/j.issn.2304-3865.2012.09.04. No abstract available.

10.

Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab.

Schwartzberg LS, Tauer KW, Hermann RC, Makari-Judson G, Isaacs C, Beck JT, Kaklamani V, Stepanski EJ, Rugo HS, Wang W, Bell-McGuinn K, Kirshner JJ, Eisenberg P, Emanuelson R, Keaton M, Levine E, Medgyesy DC, Qamar R, Starr A, Ro SK, Lokker NA, Hudis CA.

Clin Cancer Res. 2013 May 15;19(10):2745-54. doi: 10.1158/1078-0432.CCR-12-3177. Epub 2013 Feb 26.

11.

Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.

Kumthekar P, Grimm SA, Avram MJ, Kaklamani V, Helenowski I, Rademaker A, Cianfrocca M, Gradishar W, Patel J, Mulcahy M, McCarthy K, Raizer JJ.

J Neurooncol. 2013 Apr;112(2):247-55. doi: 10.1007/s11060-013-1055-0. Epub 2013 Jan 25.

PMID:
23354655
12.

A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.

Bao Y, Giovannucci EL, Kraft P, Stampfer MJ, Ogino S, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, Rifai N, Pollak MN, Cochrane BB, Kaklamani V, Lin JH, Manson JE, Fuchs CS, Wolpin BM.

J Natl Cancer Inst. 2013 Jan 16;105(2):95-103. doi: 10.1093/jnci/djs474. Epub 2012 Dec 14.

13.

A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer.

Gradishar WJ, Kaklamani V, Sahoo TP, Lokanatha D, Raina V, Bondarde S, Jain M, Ro SK, Lokker NA, Schwartzberg L.

Eur J Cancer. 2013 Jan;49(2):312-22. doi: 10.1016/j.ejca.2012.08.005. Epub 2012 Sep 3.

PMID:
22954665
14.

The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.

Economopoulou P, Kaklamani VG, Siziopikou K.

Oncologist. 2012;17(11):1394-401. doi: 10.1634/theoncologist.2012-0163. Epub 2012 Aug 31. Review.

15.

Targeting angiogenesis in metastatic breast cancer.

Reddy S, Raffin M, Kaklamani V.

Oncologist. 2012;17(8):1014-26. doi: 10.1634/theoncologist.2012-0043. Epub 2012 Jul 27.

16.

Diabetes, metformin, and breast cancer in postmenopausal women.

Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T, Ipp E, Kaklamani VG, Vitolins M, Wallace R, Gunter M, Phillips LS, Strickler H, Margolis K, Euhus DM.

J Clin Oncol. 2012 Aug 10;30(23):2844-52. doi: 10.1200/JCO.2011.39.7505. Epub 2012 Jun 11.

17.

Metabolic syndrome and triple-negative breast cancer: a new paradigm.

Davis AA, Kaklamani VG.

Int J Breast Cancer. 2012;2012:809291. doi: 10.1155/2012/809291. Epub 2011 Oct 15.

18.

Global experience with ixabepilone in breast cancer.

Kaklamani VG, Xu BH, Gomez HL.

Expert Rev Anticancer Ther. 2011 May;11(5):683-92. doi: 10.1586/era.11.41. Review.

PMID:
21554041
19.

The role of the fat mass and obesity associated gene (FTO) in breast cancer risk.

Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, Tofilon S, Agarwal S, Pasche B, Mantzoros C.

BMC Med Genet. 2011 Apr 13;12:52. doi: 10.1186/1471-2350-12-52.

20.

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.

Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B.

Metabolism. 2011 Sep;60(9):1234-43. doi: 10.1016/j.metabol.2011.01.005. Epub 2011 Mar 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk